Eli Lilly plans to invest more than $6 billion in Huntsville with the development of a new manufacturing facility, according to the company. The facility will focus on domestic production of small molecule synthetic and peptide medicines, including oral GLP-1 treatments. Once built, the project is expected to create approximately 450 jobs, including positions for […]